Saturday, June 3, 2023

FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.

from International: Top News And Analysis https://www.cnbc.com/2023/06/02/cancer-drug-shortage-fda-allows-import-of-unapproved-china-chemo-med.html

0 comments:

Post a Comment